4P-Pharma
Entity

  • 4P-Pharma

    Created in 2014
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    2,566

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    1 Rue du Professeur Calmette, 59800 Lille, France

    Lille

    France

  • Employees

    Scale: 11-50

    Estimated: 30

  • SIREN

    804204071

  • Engaged corporates

    5
    2 3

  • Added in Motherbase

    4 years, 11 months ago
Description
  • Value proposition

    4P-Pharma is a clinical stage biotech company founded in Lille in 2014. We focus on untreated serious diseases with high unmet medical needs, aiming to rapidly deliver effective, regenerated, first-in-class therapies.

    The company has developed a proprietary development engine to address the main pain points of traditional drug development: time, costs, and predictability to deliver optimized risk adjusted returns. We leverage assets with a short time to market, strong IP position, and regulatory opportunities (emergency use or conditional marketing authorizations) in blue-ocean markets.

    Translational research, Biotechnology, Pharmaceuticals, Inflammation, Abuse deterrent formulations, Research and Development, Drug Development, Preclinical development, Clinical development, Partnerships, Osteoarthritis, Covid-19, Age-related diseases, and Respiratory Infectious diseases

  • Original language

    4P-Pharma est une société de biotechnologie lilloise au stade clinique fondée en 2014, qui se consacre à la régénération active de médicament dans l’objectif de développer des thérapies curatives pour des maladies graves non traitées.

    Notre démarche se différencie du développement pharmaceutique traditionnel par une approche de développement circulaire innovante, qui réduit le temps, les coûts et les risques, afin d’apporter des solutions thérapeutiques innovantes le plus rapidement possible aux patients. 4P-Pharma exploite des candidats médicaments dont le temps de développement est réduit notamment grâce à des opportunités règlementaires (« emergency use » ou autorisation conditionnelle de mise sur le marché) avec une forte propriété intellectuelle. 4P-Pharma se positionne ainsi dans des « blue-ocean markets ».

  • 4P Pharma, Translating Science to Medicine for Patients

    4P Pharma is an R&D partner of academic and private institutions as well as life science investors. Our model is based on a co-risk co-share model.

    • https://4p-pharma.com/
Corporate interactions BETA
Corporate TypeTweets Articles
LUTECH
LUTECH
LUTECH
Other

6 Apr 2024


Europe 1
Europe 1
Broadcast Media Production and Distribution
Europe 1
Broadcast Media Production and Distribution 		Other

3 Jul 2023


Le Figaro
Le Figaro
Media, Newspaper Publishing
Le Figaro
Media, Newspaper Publishing 		Other

16 May 2023


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research 		Not capitalistic
Not partnership
Event

19 Apr 2024


Greater Paris University Hospitals - AP-HP
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care 		Not capitalistic
Partnership
Not event

20 Dec 2022


Similar entities
Last news
Show all articles
Social network dynamics